Key result
Study evaluates hospital length of stay and discharge location for 30-day CHF readmission risk.
Why the study?
The study was conducted to analyze 30-day readmission trends in CHF patients by LOS across subgroups, address potential endogeneity bias in LOS, and examine the influence of discharge location on readmission risk.
Does length of stay and discharge location influence 30-day hospital readmission risk in congestive heart failure patients?
Does length of stay and discharge location influence 30-day hospital readmission risk in congestive heart failure patients?
This study aims to evaluate the impact of length of stay and discharge location on 30-day readmission rates in CHF patients using nationwide data.
Longer hospital stays may be associated with reduced 30-day readmission risk in heart failure.
Aim We analyze 30-day hospital readmission trends of Congestive Heart Failure (CHF) patients by LOS for different sub-groups, address the potential endogeneity bias in LOS, and examine the influence of patient's discharge location on readmission risk using nationwide multi-year Big Data.
No takes yet. Share an insight, caveat, or question.
Azadeh‐Fard et al. (2022) studied this question. Hospital length of stay and discharge location were analyzed to determine their influence on 30-day readmission risk in congestive heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: